FDA approves Trulance for Chronic Idiopathic Constipation
The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.

“No one medication works for all patients suffering from chronic gastrointestinal disorders,” said Julie Beitz, M.D.,
director of the Office of Drug Evaluation III in the FDA’s Center for Drug Evaluation and Research. “With the availability of new therapies, patients and their doctors can select the most appropriate treatment for their condition.”

According to the National Institutes of Health, an estimated 42 million people are affected by constipation. Chronic idiopathic constipation is a diagnosis given to those who experience persistent constipation and for whom there is no structural or biochemical explanation....

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm537725.htm
P●●a K●●●●i and 1 others like this
Like
Comment
Share